News
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Featured news
Latest news
Allopurinol is designated as the first orphan drug for the treatment of Marfan syndrome
Study suggests loss of lung capacity begins between the ages of 20 and 25
IDIBAPS publishes its Environmental Sustainability Strategy and its Action Plan for the coming years
Researchers decode the brain mechanism that links repeated actions and reward to form stable habits
New tool to enhance the effects of immunotherapy in treating cancer
Chronic kidney disease: the silent disease
Chronic kidney disease (CKD) affects millions of people around the world; many of whom are unaware they have it. It is known as the "silent disease"1
The ‘Let’s Turn the Page!’ campaign raises €240,000 euros for cancer research through reading
The campaign’s challenge was to collect 12,000 book reviews, and it exceeded its goal. A total of 15,399 reviews were received.
A pioneering study reveals the safety of anaesthetic drugs in patients with Brugada syndrome
A retrospective study conducted at IDIBAPS-Hospital Clínic suggests that many anaesthetic drugs previously considered risky could be safe in patients1
Prehabilitation before surgery improves the functional capacity of ovarian cancer patients
This comprehensive preparation, which combines supervised physical exercise, nutritional advice and psychological support, has been associated with a1